在西部国家医学中心的墨西哥慢性丙型肝炎病毒(HCV)感染人群中,使用纤维化弹性成像和生化预测指标、APRI和FIB-4估计肝纤维化程度的相关性

IF 3.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Gerardo González-Macedo, Christian Jaramillo-Buendía, Jose Francisco Aguayo-Villaseñor, Manuel Osiris Hernández-Ceballos, Álvaro Ismael Calleros-Camarena
{"title":"在西部国家医学中心的墨西哥慢性丙型肝炎病毒(HCV)感染人群中,使用纤维化弹性成像和生化预测指标、APRI和FIB-4估计肝纤维化程度的相关性","authors":"Gerardo González-Macedo,&nbsp;Christian Jaramillo-Buendía,&nbsp;Jose Francisco Aguayo-Villaseñor,&nbsp;Manuel Osiris Hernández-Ceballos,&nbsp;Álvaro Ismael Calleros-Camarena","doi":"10.1016/j.aohep.2025.101838","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction and Objectives</h3><div>Liver fibrosis is common in HCV infection, leading to clinically significant portal hypertension and decompensated cirrhosis with high morbidity and mortality. Transient elastography is a validated study for the measurement of liver fibrosis with good predictive value, but it is not available in most public institutions. There are non-invasive measurement methods for fibrosis available, such as the FIB-4 and APRI indices. To analyze the correlation between the degree of liver fibrosis measured by elastography with the APRI and FIB-4 indices in a Mexican population with chronic HCV infection.</div></div><div><h3>Materials and Patients</h3><div>Cross-sectional, analytical, retrospective diagnostic test study. Information was obtained from the clinical records of HCV patients treated during the period from January 2017 to January 2019 in the Gastroenterology service of UMAE CMNO.</div></div><div><h3>Results</h3><div>A total of 467 patients were retrospectively analyzed; 281 met the inclusion criteria, 66.2% female and 32.8% male. Median age was 60 years, with an interquartile range of 16 years. Median weight was 62.5 kg, BMI of 24.8. The predominant HCV genotype was 1a, corresponding to 64.5%, genotype 1b was 24.7%. Genotypes 2, 3, and 4 represented 5.4%, 4.6%, and 0.8% of the population respectively. 2.2% had HIV co-infection and 0.7% had hepatitis B co-infection. 58% had a fibrosis grade of F4, 17.1%: F1, 12.1%: F2, 11%: F3, and 1.8% without evidence of fibrosis (F0) according to the elastography results. There were no statistically significant differences between male and female participants (p=0.131). Sex did not impact the development of liver fibrosis. Spearman's correlation between APRI and FIB-4 indices with liver elastography was evaluated (Figure 1). A Rho value of 0.56 and a p-value &lt; 0.001 was obtained for the APRI index and elastography. Similarly, the FIB-4 index also obtained a Rho value of 0.56 and a p-value &lt; 0.001 with respect to elastography. For the APRI index, the calculated cutoff point for each ROC curve was the same (0.75), regardless of the degree of fibrosis. It was considered a good predictor of fibrosis. For the FIB-4 index, the calculated cutoff points matched in the subgroups of F0–F2 with an optimal cutoff value of 2.645, and in the subgroups of F3-F4 with an optimal cutoff point of 2.665. This suggests that this index is a good marker for distinguishing between grade F1 and advanced fibrosis grades (F3-F4) (Table 1).</div></div><div><h3>Conclusions</h3><div>The APRI and FIB-4 indices are reliable and accurate predictors for estimating the degree of liver fibrosis in patients with chronic HCV infection, with a statistically significant correlation of the degree of liver fibrosis between the predictive indices and liver elastography.</div></div>","PeriodicalId":7979,"journal":{"name":"Annals of hepatology","volume":"30 ","pages":"Article 101838"},"PeriodicalIF":3.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Correlation in estimating the degree of liver fibrosis using elastography and biochemical predictors of fibrosis, APRI and FIB-4 in a Mexican population from the National Medical Center of the West with chronic Hepatitis C Virus (HCV) infection.\",\"authors\":\"Gerardo González-Macedo,&nbsp;Christian Jaramillo-Buendía,&nbsp;Jose Francisco Aguayo-Villaseñor,&nbsp;Manuel Osiris Hernández-Ceballos,&nbsp;Álvaro Ismael Calleros-Camarena\",\"doi\":\"10.1016/j.aohep.2025.101838\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction and Objectives</h3><div>Liver fibrosis is common in HCV infection, leading to clinically significant portal hypertension and decompensated cirrhosis with high morbidity and mortality. Transient elastography is a validated study for the measurement of liver fibrosis with good predictive value, but it is not available in most public institutions. There are non-invasive measurement methods for fibrosis available, such as the FIB-4 and APRI indices. To analyze the correlation between the degree of liver fibrosis measured by elastography with the APRI and FIB-4 indices in a Mexican population with chronic HCV infection.</div></div><div><h3>Materials and Patients</h3><div>Cross-sectional, analytical, retrospective diagnostic test study. Information was obtained from the clinical records of HCV patients treated during the period from January 2017 to January 2019 in the Gastroenterology service of UMAE CMNO.</div></div><div><h3>Results</h3><div>A total of 467 patients were retrospectively analyzed; 281 met the inclusion criteria, 66.2% female and 32.8% male. Median age was 60 years, with an interquartile range of 16 years. Median weight was 62.5 kg, BMI of 24.8. The predominant HCV genotype was 1a, corresponding to 64.5%, genotype 1b was 24.7%. Genotypes 2, 3, and 4 represented 5.4%, 4.6%, and 0.8% of the population respectively. 2.2% had HIV co-infection and 0.7% had hepatitis B co-infection. 58% had a fibrosis grade of F4, 17.1%: F1, 12.1%: F2, 11%: F3, and 1.8% without evidence of fibrosis (F0) according to the elastography results. There were no statistically significant differences between male and female participants (p=0.131). Sex did not impact the development of liver fibrosis. Spearman's correlation between APRI and FIB-4 indices with liver elastography was evaluated (Figure 1). A Rho value of 0.56 and a p-value &lt; 0.001 was obtained for the APRI index and elastography. Similarly, the FIB-4 index also obtained a Rho value of 0.56 and a p-value &lt; 0.001 with respect to elastography. For the APRI index, the calculated cutoff point for each ROC curve was the same (0.75), regardless of the degree of fibrosis. It was considered a good predictor of fibrosis. For the FIB-4 index, the calculated cutoff points matched in the subgroups of F0–F2 with an optimal cutoff value of 2.645, and in the subgroups of F3-F4 with an optimal cutoff point of 2.665. This suggests that this index is a good marker for distinguishing between grade F1 and advanced fibrosis grades (F3-F4) (Table 1).</div></div><div><h3>Conclusions</h3><div>The APRI and FIB-4 indices are reliable and accurate predictors for estimating the degree of liver fibrosis in patients with chronic HCV infection, with a statistically significant correlation of the degree of liver fibrosis between the predictive indices and liver elastography.</div></div>\",\"PeriodicalId\":7979,\"journal\":{\"name\":\"Annals of hepatology\",\"volume\":\"30 \",\"pages\":\"Article 101838\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of hepatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1665268125000626\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of hepatology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1665268125000626","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

简介与目的肝纤维化在HCV感染中很常见,可导致临床上显著的门脉高压和失代偿性肝硬化,发病率和死亡率高。瞬态弹性成像是一项有效的肝纤维化测量研究,具有良好的预测价值,但在大多数公共机构中尚不可用。目前已有非侵入性纤维化测量方法,如FIB-4和APRI指数。分析墨西哥慢性HCV感染人群中弹性成像测量的肝纤维化程度与APRI和FIB-4指数之间的相关性。材料与患者横断面、分析性、回顾性诊断试验研究。信息来自2017年1月至2019年1月在UMAE CMNO胃肠病学服务部门治疗的HCV患者的临床记录。结果共对467例患者进行回顾性分析;281例符合纳入标准,其中女性占66.2%,男性占32.8%。中位年龄为60岁,四分位数范围为16岁。中位体重为62.5 kg, BMI为24.8。HCV基因型以1a型为主,占64.5%,1b型占24.7%。基因型2、3和4分别占种群总数的5.4%、4.6%和0.8%。2.2%合并HIV感染,0.7%合并乙肝感染。根据弹性成像结果,58%的患者纤维化等级为F4, 17.1%为F1, 12.1%为F2, 11%为F3, 1.8%无纤维化证据(F0)。男性和女性参与者之间无统计学差异(p=0.131)。性别对肝纤维化的发展没有影响。评估肝弹性成像与APRI和FIB-4指数的Spearman相关性(图1)。Rho值为0.56,p值<;APRI指数和弹性图为0.001。同样,FIB-4指数的Rho值为0.56,p值为<;相对于弹性图的0.001。对于APRI指数,无论纤维化程度如何,每个ROC曲线的计算截止点都是相同的(0.75)。它被认为是纤维化的一个很好的预测指标。FIB-4指数的计算截断点在F0-F2子组中匹配,最优截断值为2.645,在F3-F4子组中匹配,最优截断值为2.665。这表明该指标是区分F1级和晚期纤维化级别(F3-F4)的良好标志(表1)。结论APRI和FIB-4指标是估计慢性HCV感染患者肝纤维化程度的可靠、准确的预测指标,预测指标与肝弹性成像之间的肝纤维化程度有统计学意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Correlation in estimating the degree of liver fibrosis using elastography and biochemical predictors of fibrosis, APRI and FIB-4 in a Mexican population from the National Medical Center of the West with chronic Hepatitis C Virus (HCV) infection.

Introduction and Objectives

Liver fibrosis is common in HCV infection, leading to clinically significant portal hypertension and decompensated cirrhosis with high morbidity and mortality. Transient elastography is a validated study for the measurement of liver fibrosis with good predictive value, but it is not available in most public institutions. There are non-invasive measurement methods for fibrosis available, such as the FIB-4 and APRI indices. To analyze the correlation between the degree of liver fibrosis measured by elastography with the APRI and FIB-4 indices in a Mexican population with chronic HCV infection.

Materials and Patients

Cross-sectional, analytical, retrospective diagnostic test study. Information was obtained from the clinical records of HCV patients treated during the period from January 2017 to January 2019 in the Gastroenterology service of UMAE CMNO.

Results

A total of 467 patients were retrospectively analyzed; 281 met the inclusion criteria, 66.2% female and 32.8% male. Median age was 60 years, with an interquartile range of 16 years. Median weight was 62.5 kg, BMI of 24.8. The predominant HCV genotype was 1a, corresponding to 64.5%, genotype 1b was 24.7%. Genotypes 2, 3, and 4 represented 5.4%, 4.6%, and 0.8% of the population respectively. 2.2% had HIV co-infection and 0.7% had hepatitis B co-infection. 58% had a fibrosis grade of F4, 17.1%: F1, 12.1%: F2, 11%: F3, and 1.8% without evidence of fibrosis (F0) according to the elastography results. There were no statistically significant differences between male and female participants (p=0.131). Sex did not impact the development of liver fibrosis. Spearman's correlation between APRI and FIB-4 indices with liver elastography was evaluated (Figure 1). A Rho value of 0.56 and a p-value < 0.001 was obtained for the APRI index and elastography. Similarly, the FIB-4 index also obtained a Rho value of 0.56 and a p-value < 0.001 with respect to elastography. For the APRI index, the calculated cutoff point for each ROC curve was the same (0.75), regardless of the degree of fibrosis. It was considered a good predictor of fibrosis. For the FIB-4 index, the calculated cutoff points matched in the subgroups of F0–F2 with an optimal cutoff value of 2.645, and in the subgroups of F3-F4 with an optimal cutoff point of 2.665. This suggests that this index is a good marker for distinguishing between grade F1 and advanced fibrosis grades (F3-F4) (Table 1).

Conclusions

The APRI and FIB-4 indices are reliable and accurate predictors for estimating the degree of liver fibrosis in patients with chronic HCV infection, with a statistically significant correlation of the degree of liver fibrosis between the predictive indices and liver elastography.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Annals of hepatology
Annals of hepatology 医学-胃肠肝病学
CiteScore
7.90
自引率
2.60%
发文量
183
审稿时长
4-8 weeks
期刊介绍: Annals of Hepatology publishes original research on the biology and diseases of the liver in both humans and experimental models. Contributions may be submitted as regular articles. The journal also publishes concise reviews of both basic and clinical topics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信